IGF-1 and BRCA1 signalling pathways in familial cancer - PubMed (original) (raw)
Review
IGF-1 and BRCA1 signalling pathways in familial cancer
Haim Werner et al. Lancet Oncol. 2012 Dec.
Abstract
The insulin-like growth factor (IGF) system has a direct effect on cellular proliferation and survival, and interacts with genetic and environmental factors implicated in causing cancer. Experimental, clinical, and epidemiological evidence show that the IGF signalling pathways are important mediators in the biochemical and molecular chain of events that lead from a phenotypically normal cell to one harbouring neoplastic traits. BRCA1 and BRCA2 have an important role in the development of hereditary and sporadic breast and ovarian cancer. Recent evidence suggests that risk of cancer conferred by BRCA mutations can be modified by genetic and environmental factors, including ambient concentrations of IGF-1 and polymorphisms in IGF system components. This Review addresses interactions between the IGF and BRCA1 signalling pathways, and emphasises the convergence of IGF-1-mediated cell survival, proliferative pathways, and BRCA1-mediated tumour protective pathways. Understanding the complex interactions between these signalling pathways might improve our understanding of basic molecular oncology processes and help to identify new molecular targets, predictive biomarkers, and approaches for optimising cancer therapies.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
- Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations.
Hudelist G, Wagner T, Rosner M, Fink-Retter A, Gschwantler-Kaulich D, Czerwenka K, Kroiss R, Tea M, Pischinger K, Köstler WJ, Attems J, Mueller R, Blaukopf C, Kubista E, Hengstschläger M, Singer CF. Hudelist G, et al. Endocr Relat Cancer. 2007 Dec;14(4):1053-62. doi: 10.1677/ERC-06-0075. Endocr Relat Cancer. 2007. PMID: 18045956 - Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations.
Maor S, Yosepovich A, Papa MZ, Yarden RI, Mayer D, Friedman E, Werner H. Maor S, et al. Cancer Lett. 2007 Nov 18;257(2):236-43. doi: 10.1016/j.canlet.2007.07.019. Epub 2007 Sep 4. Cancer Lett. 2007. PMID: 17766039 - Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene.
Abramovitch S, Werner H. Abramovitch S, et al. Horm Metab Res. 2003 Nov-Dec;35(11-12):758-62. doi: 10.1055/s-2004-814154. Horm Metab Res. 2003. PMID: 14710355 - An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
Alexia C, Fallot G, Lasfer M, Schweizer-Groyer G, Groyer A. Alexia C, et al. Biochem Pharmacol. 2004 Sep 15;68(6):1003-15. doi: 10.1016/j.bcp.2004.05.029. Biochem Pharmacol. 2004. PMID: 15313394 Review. - Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer.
Sarfstein R, Maor S, Reizner N, Abramovitch S, Werner H. Sarfstein R, et al. Mol Cell Endocrinol. 2006 Jun 27;252(1-2):241-6. doi: 10.1016/j.mce.2006.03.018. Epub 2006 Apr 27. Mol Cell Endocrinol. 2006. PMID: 16647191 Review.
Cited by
- Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways.
Werner H, Sarfstein R, LeRoith D, Bruchim I. Werner H, et al. Front Oncol. 2016 Jun 23;6:159. doi: 10.3389/fonc.2016.00159. eCollection 2016. Front Oncol. 2016. PMID: 27446805 Free PMC article. Review. - Effects of Silver Nanoparticles and Silver Nitrate on mRNA and microRNA Expression in Human Hepatocellular Carcinoma Cells (HepG2).
Thai SF, Jones CP, Robinette BL, Ren H, Vallanat B, Fisher AA, Kitchin KT. Thai SF, et al. J Nanosci Nanotechnol. 2021 Nov 1;21(11):5414-5428. doi: 10.1166/jnn.2021.19481. J Nanosci Nanotechnol. 2021. PMID: 33980351 Free PMC article. - Brca1 is expressed in human microglia and is dysregulated in human and animal model of ALS.
Noristani HN, Sabourin JC, Gerber YN, Teigell M, Sommacal A, Vivanco Md, Weber M, Perrin FE. Noristani HN, et al. Mol Neurodegener. 2015 Aug 1;10:34. doi: 10.1186/s13024-015-0023-x. Mol Neurodegener. 2015. PMID: 26227626 Free PMC article. - Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB.
Cui Y, Wu H, Yang L, Huang T, Li J, Gong X, Li L, Sun X, Mao F, Wang Y. Cui Y, et al. Front Oncol. 2021 Apr 16;11:665832. doi: 10.3389/fonc.2021.665832. eCollection 2021. Front Oncol. 2021. PMID: 33937078 Free PMC article. - Prognostic model construction and validation of esophageal cancer cellular senescence-related genes and correlation with immune infiltration.
Zheng S, Lin N, Wu Q, He H, Yang C. Zheng S, et al. Front Surg. 2023 Jan 25;10:1090700. doi: 10.3389/fsurg.2023.1090700. eCollection 2023. Front Surg. 2023. PMID: 36761024 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous